On Tuesday, Beta Bionics Inc (NASDAQ: BBNX) was 6.19% up from the session before settling in for the closing price of $29.57. A 52-week range for BBNX has been $8.89 – $32.71.
When this article was written, the company’s average yearly earnings per share was at 77.02%. With a float of $33.42 million, this company’s outstanding shares have now reached $43.99 million.
Beta Bionics Inc (BBNX) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Beta Bionics Inc stocks. The insider ownership of Beta Bionics Inc is 24.09%, while institutional ownership is 94.93%. The most recent insider transaction that took place on Jan 02 ’26, was worth 230,950. In this transaction Chief Product Officer of this company sold 7,800 shares at a rate of $29.61, taking the stock ownership to the 82,952 shares. Before that another transaction happened on Jan 02 ’26, when Company’s Chief Financial Officer sold 20,000 for $29.53, making the entire transaction worth $590,680. This insider now owns 42,614 shares in total.
Beta Bionics Inc (BBNX) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -2.72 earnings per share (EPS) during the time that was less than consensus figure (set at -1.22) by -1.5. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 77.02% per share during the next fiscal year.
Beta Bionics Inc (NASDAQ: BBNX) Trading Performance Indicators
You can see what Beta Bionics Inc (BBNX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 9.83. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 15.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.79, a number that is poised to hit -0.39 in the next quarter and is forecasted to reach -1.75 in one year’s time.
Technical Analysis of Beta Bionics Inc (BBNX)
Looking closely at Beta Bionics Inc (NASDAQ: BBNX), its last 5-days average volume was 0.71 million, which is a jump from its year-to-date volume of 0.7 million. As of the previous 9 days, the stock’s Stochastic %D was 42.72%.
During the past 100 days, Beta Bionics Inc’s (BBNX) raw stochastic average was set at 92.78%, which indicates a significant increase from 80.55% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.69 in the past 14 days, which was higher than the 1.66 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $28.76, while its 200-day Moving Average is $19.48. However, in the short run, Beta Bionics Inc’s stock first resistance to watch stands at $32.17. Second resistance stands at $32.94. The third major resistance level sits at $34.46. If the price goes on to break the first support level at $29.88, it is likely to go to the next support level at $28.36. Should the price break the second support level, the third support level stands at $27.59.
Beta Bionics Inc (NASDAQ: BBNX) Key Stats
There are 44,025K outstanding shares of the company, which has a market capitalization of 1.38 billion. As of now, sales total 65,120 K while income totals -54,760 K. Its latest quarter income was 27,250 K while its last quarter net income were -14,210 K.
